Arkolith/Insider Trading/AGRX/Form 4

Reilly Dennis

Chief Financial OfficerAGILE THERAPEUTICS INC (AGRX) · full profile →Form 4 · filed May 12, 2021
Net Buying
Open-Market Buys
$27K
Open-Market Sells
$0
Net Open-Market Flow
$27K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 11, 2021Buy(P)20K$1.35$27K176K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-065161) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML